ANEW Medical - Multiplikator Forward P/S KLTO
Klotho Neurosciences Inc (KLTO) is currently implementing a long-term plan to develop innovative neurobiological treatments. The funding for preclinical trials of new drugs is based on attracted investments. The development of biologics based on the Klotho protein to combat dementia is supported by patents. The forward P/S ratio demonstrates market demand, with the parameter value equal to .
KLTO (anewmeds.com): rincian analitis lan laporan miturut indikator
- rega pasar lan target rega analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Utang marang Ekuitas Klotho Neurosciences Inc|KLTO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Klotho Neurosciences|KLTO - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku KLTO|KLTO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Klotho Neurosciences|Rasio cepet anewmeds.com
- indikator pendapatan resik lan kelipatan nilai:
KLTO - Penghasilan resik perusahaan|Bathi sing dikarepake Klotho Neurosciences Inc|KLTO - Pangali rega marang bathi|Pangali Forward P/E Klotho Neurosciences|KLTO - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA KLTO|KLTO - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Klotho Neurosciences|KLTO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan anewmeds.com|KLTO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Klotho Neurosciences Inc
- data total pendapatan lan volume dodolan:
Analisis komprehensif perusahaan:ANEW Medical, Inc. KLTO
Analyzing the forward price-to-sales ratio chart allows for an assessment of the market value of Klotho Neurosciences Inc (KLTO) through the lens of its scientific authority in neurodegeneration therapy. This indicator compares current market capitalization with expected sales, enabling investors to determine the business's margin of safety and identify hidden undervaluation or risks of declining demand for the company's innovative drugs.
Pesaing Klotho Neurosciences Inc (KLTO)
Rasio rega marang prakiraan pendapatan Biogen BIIB|NBIX: Kapitalisasi marang prakiraan pendapatan|Regencell - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Axsome Corp|ACAD (ACADIA Pharmaceuticals) - Multiplikator forward rega marang pendapatan|xenon-pharma.com (XENE) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Viking Therapeutics, Inc.|SUPN: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Catalyst Pharmaceuticals Inc (CPRX)|DNLI - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Harmony Biosciences HRMY|Rasio kapitalisasi marang dodolan sing dikarepake biohavenpharma.com (BHVN)|Amylyx Pharmaceuticals, Inc. - Multiplikator Forward P/S|Trevi Therapeutics Inc (TRVI) - Multiplikator forward rega marang pendapatan|PRAX: Multiplikator Forward P/S|AVXL - Rasio kapitalisasi marang dodolan sing dikarepake|CBLL (CeriBell, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Prothena Corporation PRTA|Rasio rega marang prakiraan pendapatan Alector, Inc. (ALEC)|Annexon Biosciences - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S OMER (Omeros)|NGNE - Multiplikator forward rega marang pendapatan|AC Immune - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep voyagertherapeutics.com|Neumora Therapeutics, Inc. (NMRA) - Rasio rega marang prakiraan pendapatan|SCLX - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan TVGN|ACOG: Rega forward marang dodolan|Multiplikator Forward P/S CGTX|Rasio kapitalisasi marang dodolan sing dikarepake inhibikase.com|Rasio rega marang prakiraan pendapatan Cassava Sciences SAVA|ASRT: Kapitalisasi marang prakiraan pendapatan|Coya - Multiplikator Forward P/S|Vistagen Therapeutics (VTGN) - Multiplikator forward rega marang pendapatan|ovidrx.com (OVID) - Rasio rega marang prakiraan pendapatan|acumenpharm.com (ABOS) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan CervoMed|Rasio rega marang prakiraan pendapatan ATHE|Multiplikator forward rega marang pendapatan CLNN (Clene Inc.)|Rasio rega marang pendapatan sing dikarepake PEPG|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|relmada.com (RLMD) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ANVS - Rasio rega marang prakiraan pendapatan|GRCE (Grace Therapeutics, Inc.) - Kapitalisasi marang prakiraan pendapatan|AIFF: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NeuroSense Therapeutics Ltd. (NRSN)|Multiplikator forward rega marang pendapatan RVPH|Multiplikator Forward P/S MetaVia, Inc.|Rasio rega marang prakiraan pendapatan NeurAxis (NRXS)|HSDT (heliusmedical.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Passage Bio PASG|Neuphoria Therapeutics, Inc. (NEUP) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|NERV - Rasio rega marang prakiraan pendapatan|ATHA - Multiplikator Forward P/S|Addex Therapeutics Ltd (ADXN) - Rasio rega marang prakiraan pendapatan|ALZN (Alzamend Neuro) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Cyclerion Therapeutics Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Protagenic PTIX|Multiplikator forward rega marang pendapatan KTTA (Pasithea Therapeutics)|Rasio rega marang pendapatan sing dikarepake CRGT|Multiplikator Forward P/S ATXI (Avenue Therapeutics, Inc.)|Rega forward marang dodolan BCLI|CARA - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Chromocell|ELYM (eliemtx.com) - Multiplikator forward rega marang pendapatan|Intra-Cellular Therapies, Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Longboard Pharmaceuticals, Inc.|Kapitalisasi marang prakiraan pendapatan MRNS (Marinus Pharmaceuticals Inc)|Multiplikator Forward P/S NKGN|NRBO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Sage Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S synaptogen.com SNPX|TRVN - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan VIGL (Vigil Neuroscience)|Anew Medical (WENA) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cerevel Corp (CERE)
